灵麦项目推荐LMLB120 - 干眼症，拜拜啦~ Bye Bye, Dry Eye~

欢迎分享，转载有版权, 快快登录 lingmed.net/reports 下载全文吧

本周灵麦医药为您推荐一款治疗干眼症的眼药水

干眼症（Dry eye syndrome, DES），指任何原因造成的泪液质或量异常或动力学异常，导致泪膜稳定性下降，并伴有眼部不适和（或）眼表组织病变特征的多种疾病的总称。随着人口老龄化和电子设备普及的，未来中国干眼症的患病率将不断增加，存在着巨大的商业机遇。

• 2016年全球及中国干眼症市场情况及未来市场预测

• LMP0825项目产品技术，临床进展，竞争格局 

Bye Bye, Dry Eye- Novel Asset Feeding For You 

This week Lingmed shares with you a novel asset in the area of dry eye. Dry eye syndrome (DES), which is also known as Keratoconjunctivitis sicca (KCS), is a complex condition characterized by increased osmolarity of the tear film, inflammation of the ocular surface and tear-producing glands. With the aging population and increasingly popularity of electronic equipment, the prevalence of dry eye in China will continue to increase in the future, and existed huge business opportunities 

• Worldwide and Chinese dry eye market in 2016 and market forecast in 2022

• The  product technology, clinical progress and competitive landscape of LMP0825

想要下载完整报告? 

请登录 www.lingmed.net/reports

或点击下方“阅读原文”马上下载